ACE inhibitor improves survival in advanced HF

Decreased mortality in patients with advanced NYHA class III or IV heart failure after treatment with enalapril compared to placebo (p = 0.003).

Data from: The CONSENSUS Trial Study Group, N Engl J Med 1987; 316:1429.

Graphic 62325 Version 1.0